Videos
May 14, 2021
Jeremie Lever, MD, PhD, discusses results from an analysis evaluating the knowledge of and access to technology for telehealth services among patients with cancer.
Videos
May 12, 2021
Christopher Su, MD, discusses results from a study investigating the differences in costs and health care utilization between blood cancer survivors and solid cancer survivors, and examining what their survivorship looks like.
Videos
May 04, 2021
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Videos
May 04, 2021
Lucio Gordan, MD, discusses results from a study analyzing the impact of late dosing of two leuprolide acetate formulations on testosterone suppression for patients with prostate cancer.
Conference Coverage
April 16, 2021
Study results show that immunotherapy is the most common next line of therapy after discontinuation of an EGFR-TKI and platinum-based chemotherapy for metastatic NSCLC.
Conference Coverage
April 08, 2021
Significant disparities in technological knowledge and access to telehealth exist among cancer patients and are largely associated with demographic characteristics.

Conference Coverage
April 07, 2021
Treatment guided by biomarker testing is associated with improved survival outcomes in patients with advanced or metastatic NSCLC.
Conference Coverage
April 06, 2021
Patients with NSCLC who receive pembrolizumab with chemotherapy are more likely to remain on therapy past 90 days than those who received chemotherapy alone.